within Pharmacolibrary.Drugs.R_RespiratorySystem.R01A_DecongestantsAndOtherNasalPreparationsForTopicalUse.R01AX06_Mupirocin;

model Mupirocin
  extends Pharmacolibrary.Drugs.ATC.R.R01AX06;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>R01AX06</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Mupirocin is a topical antibiotic derived from Pseudomonas fluorescens, primarily used to treat skin infections such as impetigo and secondary wound infections caused by susceptible bacteria, including Staphylococcus aureus and Streptococcus pyogenes. It acts by inhibiting bacterial isoleucyl-tRNA synthetase. Mupirocin is approved and widely used today, mostly as a topical ointment or nasal cream.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for topical or intranasal application in healthy adults; mupirocin has negligible systemic absorption when administered topically or intranasally.</p><h4>References</h4><ol><li><p>Hariprasad, SM, &amp; Mieler, WF (2016). Antibiotics. <i>Developments in ophthalmology</i> 55 344–356. DOI:<a href=&quot;https://doi.org/10.1159/000438961&quot;>10.1159/000438961</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26501865/&quot;>https://pubmed.ncbi.nlm.nih.gov/26501865</a></p></li><li><p>Parenti, MA, et al., &amp; Leyden, JJ (1987). Mupirocin: a topical antibiotic with a unique structure and mechanism of action. <i>Clinical pharmacy</i> 6(10) 761–770. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3146455/&quot;>https://pubmed.ncbi.nlm.nih.gov/3146455</a></p></li><li><p>Pappa, KA (1990). The clinical development of mupirocin. <i>Journal of the American Academy of Dermatology</i> 22(5 Pt 1) 873–879. DOI:<a href=&quot;https://doi.org/10.1016/0190-9622(90)70116-y&quot;>10.1016/0190-9622(90)70116-y</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2112164/&quot;>https://pubmed.ncbi.nlm.nih.gov/2112164</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Mupirocin;
